“The journey of a thousand miles begins with one step.”
Shane Shahrestani M.D., Ph.D., M.S., is a leader in next-generation diagnostic technologies for stroke. He developed and patented a handheld eddy current damping stroke sensor that can differentiate stroke subtypes and generate an image of potential stroke in minutes, allowing for faster diagnosis and treatment. Shahrestani’s research was awarded an R01 grant from the National Institutes of Health (NIH), worth more than $2.4 million, funding an early-stage clinical trial of the stroke device. Separately, during the COVID-19 pandemic, Shahrestani led a team that developed a wearable pulmonary function sensor to allow for remote lung monitoring while limiting contact with sick patients. He serves as the Co-Founder of StrokeDx.
Alexander Ballatori is an MD candidate at the Keck School of Medicine of USC with 10 years of research leading to 26 accepted publications, 1 textbook chapter, 28 podium presentations, and 24 poster presentations. He has received $110,000 in funding for his research and was a recipient of the Discovery Grant in Research at the University of Rochester Medical Center. After graduating from the University of Rochester with a degree in Biology and Chemistry, he worked at UC San Francisco where he coordinated clinical trials, presenting his research to the FDA on behalf of multiple Orthopedic device companies.
Our Journey So Far
THE START OF AN IDEA
Shane started as a medical engineering Ph.D. student in Dr. Yu-Chong Tai’s lab at Caltech, where portable stroke detection quickly became his interest and thesis research topic.
HUMAN TRIALS BEGIN
After receiving IRB approval at the Keck Hospital of USC, live human clinical trials were started. The data collected at this stage proved the potential of the technology underlying StrokeDx.